Research ArticleOriginal Research

Barriers and Facilitators to Using a Clinical Decision Support Tool for Opioid Use Disorder in Primary Care

Stephanie A. Hooker, Leif I. Solberg, Kathleen M. Miley, Caitlin M. Borgert-Spaniol and Rebecca C. Rossom
The Journal of the American Board of Family Medicine May 2024, 37 (3) 389-398; DOI: https://doi.org/10.3122/jabfm.2023.230308R1

References

  1. 1.↵
    1. Porter J,
    2. Boyd C,
    3. Skandari MR,
    4. Laiteerapong N
    . Revisiting the time needed to provide adult primary care. J Gen Intern Med 2023;38:147–55.
    OpenUrl
  2. 2.↵
    1. Privett N,
    2. Guerrier S
    . Estimation of the time needed to deliver the 2020 USPSTF Preventive Care Recommendations in primary care. Am J Public Health 2021;111:145–9.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Spencer MR,
    2. Miniño AM,
    3. Warner M
    . Drug overdose deaths in the United States, 2001–2021. NCHS data brief 2022;1–8.
  4. 4.↵
    1. Wakeman SE,
    2. Larochelle MR,
    3. Ameli O,
    4. et al
    . Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open 2020;3:e1920622. Feb 5.
    OpenUrl
  5. 5.
    1. Samples H,
    2. Nowels MA,
    3. Williams AR,
    4. Olfson M,
    5. Crystal S
    . Buprenorphine after nonfatal opioid overdose: reduced mortality risk in Medicare disability beneficiaries. Am J Prev Med 2023;65(1):19–29.
    OpenUrl
  6. 6.↵
    1. Sun T,
    2. Katenka N,
    3. Kogut S,
    4. Bratberg J,
    5. Rich J,
    6. Buchanan A
    . Evaluation of the effectiveness of buprenorphine-naloxone on opioid overdose and death among insured patients with opioid use disorder in the United States. Pharmacoepidemiology 2022;1:101–12.
    OpenUrl
  7. 7.↵
    1. Raisch DW,
    2. Campbell HM,
    3. Garnand DA,
    4. et al
    . Health-related quality of life changes associated with buprenorphine treatment for opioid dependence. Qual Life Res 2012;21:1177–83.
    OpenUrlPubMed
  8. 8.↵
    1. Korthuis PT,
    2. McCarty D,
    3. Weimer M,
    4. et al
    . Primary care-based models for the treatment of opioid use disorder: a scoping review. Ann Intern Med 2017;166:268–78.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Schuler MS,
    2. Saloner B,
    3. Gordon AJ,
    4. Dick AW,
    5. Stein BD
    . National trends in buprenorphine treatment for opioid use disorder from 2007 to 2018. Substance Abuse 2023;8897077231179576.
  10. 10.↵
    1. Gordon AJ,
    2. Saxon AJ,
    3. Kertesz S,
    4. et al
    . Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug Alcohol Depend 2023;248:109902.
    OpenUrl
  11. 11.↵
    1. Lapham G,
    2. Boudreau DM,
    3. Johnson EA,
    4. et al
    . Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend 2020;207:107732.
    OpenUrl
  12. 12.↵
    1. Cole ES,
    2. DiDomenico E,
    3. Cochran G,
    4. et al
    . The role of primary care in improving access to medication-assisted treatment for rural Medicaid enrollees with opioid use disorder. J Gen Intern Med 2019;34:936–43.
    OpenUrlCrossRef
  13. 13.
    1. Kane C,
    2. Leiner C,
    3. Harless C,
    4. Foley KA,
    5. Fagan EB,
    6. Wilson CG
    . The value of treating opioid use disorder in family medicine: from the patient perspective. J Am Board Fam Med 2020;33:611–5.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. McGinty EE,
    2. Daumit GL
    . Integrating mental health and addiction treatment into general medical care: the role of policy. Psychiatr Serv 2020;71:1163–9.
    OpenUrl
  15. 15.↵
    1. McBain RK,
    2. Dick A,
    3. Sorbero M,
    4. Stein BD
    . Growth and distribution of buprenorphine-waivered providers in the United States, 2007–2017. Ann Intern Med 2020;172:504–6.
    OpenUrl
  16. 16.↵
    1. Marino LA,
    2. Campbell AN,
    3. Nunes EV,
    4. Sederer LI,
    5. Dixon LB
    . Factors influencing buprenorphine prescribing among physicians in New York State. J Addict 2019;2019:1–5.
    OpenUrl
  17. 17.↵
    1. Knopf A
    . DEA supports removal of buprenorphine regulations. Alcoholism & Drug Abuse Weekly 2023;35:5–6.
    OpenUrl
  18. 18.↵
    1. Hutchinson E,
    2. Catlin M,
    3. Andrilla CH,
    4. Baldwin LM,
    5. Rosenblatt RA
    . Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med 2014;12:128–33.
    OpenUrlAbstract/FREE Full Text
  19. 19.
    1. Krupp J,
    2. Hung F,
    3. LaChapelle T,
    4. et al
    . Impact of policy change on access to medication for opioid use disorder in primary care. South Med J 2023;116:333–40.
    OpenUrl
  20. 20.
    1. Louie DL,
    2. Assefa MT,
    3. McGovern MP
    . Attitudes of primary care physicians toward prescribing buprenorphine: a narrative review. BMC Fam Pract 2019;20:157.
    OpenUrl
  21. 21.↵
    1. Mackey K,
    2. Veazie S,
    3. Anderson J,
    4. Bourne D,
    5. Peterson K
    . Barriers and facilitators to the use of medications for opioid use disorder: a rapid review. J Gen Intern Med 2020;35:954–63.
    OpenUrl
  22. 22.↵
    1. Tesema L,
    2. Marshall J,
    3. Hathaway R,
    4. et al
    . Training in office-based opioid treatment with buprenorphine in US residency programs: a national survey of residency program directors. Substance Aabuse 2018;39:434–40.
    OpenUrl
  23. 23.↵
    1. Sutton RT,
    2. Pincock D,
    3. Baumgart DC,
    4. Sadowski DC,
    5. Fedorak RN,
    6. Kroeker KI
    . An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med 2020;3:17.
    OpenUrl
  24. 24.↵
    1. Osheroff JA,
    2. Teich JM,
    3. Middleton B,
    4. Steen EB,
    5. Wright A,
    6. Detmer DE
    . A roadmap for national action on clinical decision support. J Am Med Inform Assoc 2007;14:141–5.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Kwan JL,
    2. Lo L,
    3. Ferguson J,
    4. et al
    . Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ 2020;370:m3216.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Sperl-Hillen JM,
    2. Crain AL,
    3. Margolis KL,
    4. et al
    . Clinical decision support directed to primary care patients and providers reduces cardiovascular risk: a randomized trial. J Am Med Inform Assoc 2018;25:1137–46.
    OpenUrl
  27. 27.↵
    1. Solberg LI,
    2. Hooker SA,
    3. Rossom RC,
    4. Bergdall A,
    5. Crabtree BF
    . Clinician perceptions about a decision support system to identify and manage opioid use disorder. J Am Board Fam Med 2021;34(6):1096–102.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Hooker SA,
    2. Essien IJ,
    3. Borgert-Spaniol CM,
    4. Rossom RC,
    5. Olson AW,
    6. Romagnoli KM,
    7. Solberg LI
    . Patient perspectives on opioid risk discussions in primary care. J Patient Cent Res Rev 2022;9(4):253.
    OpenUrlCrossRef
  29. 29.↵
    1. Bart GB,
    2. Saxon A,
    3. Fiellin DA,
    4. et al
    . Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report. Addict Sci Clin Pract 2020;15:4.
    OpenUrl
  30. 30.↵
    1. Rossom RC,
    2. Crain AL,
    3. O'Connor PJ,
    4. et al
    . Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care. Contemp Clin Trials 124:107012.
  31. 31.↵
    1. Saunders B,
    2. Sim J,
    3. Kingstone T,
    4. et al
    . Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant 2018;52:1893–907.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Elo S,
    2. Kyngäs H
    . The qualitative content analysis process. J Adv Nurs 2008;62:107–15.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Miles MB,
    2. Huberman AM
    . Qualitative data analysis: a sourcebook of new methods. Thousand Oaks, CA: Sage Publications; 1984.
  34. 34.↵
  35. 35.↵
    1. Saitz R,
    2. Daaleman TP
    . Now is the time to address substance use disorders in primary care. Ann Fam Med 2017;15:306–8.
    OpenUrlFREE Full Text
  36. 36.↵
    1. Scott JG,
    2. Cohen D,
    3. Dicicco-Bloom B,
    4. Miller WL,
    5. Stange KC,
    6. Crabtree BF
    . Understanding healing relationships in primary care. Ann Fam Med 2008;6:315–22.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Hooker SA,
    2. Crain AL,
    3. LaFrance AB,
    4. et al
    . A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians. Addict Sci Clin Pract 2023;18:10.
    OpenUrl
  38. 38.
    1. Kennedy-Hendricks A,
    2. Busch SH,
    3. McGinty EE,
    4. et al
    . Primary care physicians’ perspectives on the prescription opioid epidemic. Drug Alcohol Depend 2016;165:61–70.
    OpenUrlPubMed
  39. 39.↵
    1. Franz B,
    2. Dhanani LY,
    3. Brook DL
    . Physician blame and vulnerability: novel predictors of physician willingness to work with patients who misuse opioids. Addict Sci Clin Pract 2021;16:33.
    OpenUrl
  40. 40.↵
    1. Gutierrez JC,
    2. Terwiesch C,
    3. Pelak M,
    4. Pettit AR,
    5. Marcus SC
    . Characterizing primary care visit activities at Veterans Health Administration clinics. J Healthc Manag 2015;60:30–42.
    OpenUrl
  41. 41.↵
    1. Venkatesh V,
    2. Bala H
    . Technology acceptance model 3 and a research agenda on interventions. Decision Sci 2008;39:273–315.
    OpenUrlCrossRefWeb of Science
  42. 42.↵
    1. Meunier PY,
    2. Raynaud C,
    3. Guimaraes E,
    4. Gueyffier F,
    5. Letrilliart L
    . Barriers and facilitators to the use of clinical decision support systems in primary care: a mixed-methods systematic review. Ann Fam Med 2023;21:57–69.
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    1. Liu S,
    2. Reese TJ,
    3. Kawamoto K,
    4. Del Fiol G,
    5. Weir C
    . A theory-based meta-regression of factors influencing clinical decision support adoption and implementation. Journal of the American Medical Informatics Association 2021;00:1–9.
    OpenUrl
  44. 44.↵
    1. Ford E,
    2. Edelman N,
    3. Somers L,
    4. et al
    . Barriers and facilitators to the adoption of electronic clinical decision support systems: a qualitative interview study with UK general practitioners. BMC Med Inform Decis Mak 2021;21:193.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Gold R,
    2. Larson AE,
    3. Sperl-Hillen JM,
    4. et al
    . Effect of clinical decision support at community health centers on the risk of cardiovascular disease: a cluster randomized clinical trial. JAMA Netw Open 2022;5:e2146519.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords